RxDoctor Payments Data

Eugenie Chetangie

Family · Hackettstown, NJNPI 1447859848

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,779 of the $1,987 with a category attached, or 89.5%. 26 manufacturers reported payments, led by AstraZeneca at 26.1% of the total. 2025 is the largest year on record at $822, 7.0 times the $118 reported in 2022.

$1,987in general payments, 2019–2025

Across 103 payments — averaging $19.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$519
  • Daiichi Sankyo Inc.$451
  • Incyte Corporation$123
  • Bayer$104
  • Pfizer$90
  • AbbVie$86
  • plus $614 from 20 others

What the payments were for

  • Food & beverage$1,77990%
  • Education$20810%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,987 in reported general payments places this provider in the 85th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey →

Other family in Hackettstown

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →